CytomX Therapeutics, Inc. is in its Venus mahadasha (20 Apr 2021 to 20 Apr 2041), Moon antardasha (20 Aug 2025 to 20 Apr 2027) and Mercury pratyantar (10 Aug 2026 to 4 Nov 2026).
Next: pratyantar Ketu from 4 Nov 2026; antardasha Mars from 20 Apr 2027; mahadasha Sun from 20 Apr 2041.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Kanya (Virgo) | 20°54′ | 1st | Hasta 4 |
| Moon | Simha (Leo) | 2°48′ | 12th | Magha 1 |
| Mars | Simha (Leo) | 14°20′ | 12th | Purva Phalguni 1 |
| Mercury (R) | Kanya (Virgo) | 6°57′ | 1st | Uttara Phalguni 4 |
| Jupiter | Simha (Leo) | 18°19′ | 12th | Purva Phalguni 2 |
| Venus | Simha (Leo) | 5°49′ | 12th | Magha 2 |
| Saturn | Vrishchika (Scorpio) | 7°38′ | 3rd | Anuradha 2 |
| Rahu | Kanya (Virgo) | 6°01′ | 1st | Uttara Phalguni 3 |
| Ketu | Meena (Pisces) | 6°01′ | 7th | Uttara Bhadrapada 1 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how CTMX moved in each period against the S&P 500, transits, fundamentals and news.